|
Market Closed -
Nasdaq
00:00:00 04/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 7.250 USD | -0.96% |
|
+7.41% | -60.08% |
| 10-23 | Avalo Therapeutics Shares Fall After HC Wainwright Downgrade | MT |
| 10-23 | Guggenheim Downgrades Avalo Therapeutics to Neutral From Buy | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.96% | +7.41% | -51.63% | -59.83% | -60.08% | -56.51% | -70.76% | -99.89% | -99.93% | 389M | |
| -2.43% | -4.38% | -19.16% | +5.28% | +49.25% | +40.32% | +55.64% | +2.15% | - | 60.57B | |
| +2.07% | +5.40% | +15.48% | +19.30% | +23.43% | +22.93% | +100.30% | -13.86% | +273.34% | 55.51B | |
| +4.56% | +3.51% | +1.50% | +13.27% | +15.04% | +12.34% | +78.56% | +189.13% | +6,428.90% | 55.22B | |
| +1.61% | -3.30% | +1.70% | +12.53% | +16.49% | +22.77% | +33.16% | +3.14% | +263.65% | 43.27B | |
| -1.74% | -3.02% | -0.86% | +13.14% | +16.85% | +13.83% | +93.17% | -5.01% | +1,034.91% | 40.36B | |
| +3.22% | +4.30% | -6.01% | +6.46% | +143.85% | +227.37% | +776.49% | +487.15% | - | 41.63B | |
| -0.58% | -4.45% | +55.49% | +96.81% | +82.34% | +95.71% | +84.62% | +21.58% | +219.17% | 33.29B | |
| -1.09% | +0.69% | +4.00% | +4.23% | +10.16% | +14.20% | +45.26% | +9.99% | +150.92% | 32.27B | |
| -4.46% | +9.98% | -6.01% | +6.08% | -39.99% | -43.92% | +320.28% | +222.15% | +908.11% | 22.91B | |
| +12.22% | +4.32% | -12.78% | +19.43% | +53.69% | +38.93% | -3.55% | -53.89% | - | 22.52B | |
| -0.70% | -0.16% | -10.30% | -5.78% | -8.70% | -16.39% | -9.25% | -70.58% | - | 21.83B | |
| +2.37% | -1.53% | +10.68% | +15.73% | +18.13% | +11.69% | +141.96% | +195.88% | +2,182.39% | 18.56B | |
| +1.35% | +2.53% | +17.05% | +28.48% | +41.70% | +47.81% | +74.19% | -14.69% | +121.60% | 16.95B | |
| +3.11% | +10.65% | +23.84% | +31.33% | +64.98% | +89.99% | +244.33% | +275.83% | +608.92% | 17.64B | |
| +0.48% | +1.76% | +9.79% | +2.76% | - | - | - | - | - | 16.43B | |
| +3.94% | -1.94% | +21.26% | +52.41% | +76.39% | +96.73% | +93.43% | -9.27% | +422.06% | 16.8B | |
| -0.67% | +11.36% | +25.75% | +28.63% | +11.83% | +20.72% | -21.05% | -26.06% | +165.74% | 15.27B | |
| +2.94% | +2.94% | +5.15% | +5.15% | +189.12% | +172.86% | +342.22% | +1,453.01% | +833.73% | 15.47B | |
| -0.87% | +7.83% | +1.53% | +68.95% | +31.75% | -12.30% | - | - | - | 14.16B | |
| Average | +1.40% | +3.32% | +4.32% | +18.22% | +38.75% | +42.06% | +132.17% | +142.60% | +965.25% | 28.05B | |
| Weighted average by Cap. | +1.41% | +2.24% | +4.98% | +19.60% | +41.63% | +47.00% | +144.87% | +119.77% | +1,386.00% |
- Stock Market
- Stocks
- AVTX Stock
- Sector Avalo Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
